Similar results were obtained for the other MHC class I genes HLA-B and HLA-C (Supplementary Figure 2), suggesting that the immune system plays a role in controlling hypermutated MSI/CMS1 tumours in the early stages of the disease. The gene discussed is HLA-B; the disease is neoplasm.